Periconceptional parental conditions and perimembranous ventricular septal defects in the offspring

Kim P J Wijnands1, Gerda A Zeilmaker, Willemijn M Meijer

  • 1Department of Obstetrics and Gynecology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.

Insights

Perimembranous ventricular septal defects (pVSD) are linked to four parental conditions before conception. Maternal factors include family history of heart disease, medication use, and advanced age. Paternal exposure to phthalates also increases pVSD risk.

Area of Science:

  • Cardiology
  • Pediatrics
  • Public Health

Background:

  • Perimembranous ventricular septal (pVSD) defects represent the most frequent congenital heart disease phenotype.
  • Several parental factors have been identified as potential contributors to pVSD risk in offspring.
  • Understanding nongenetic parental conditions is crucial for developing preventive strategies.

Purpose of the Study:

  • To investigate the associations between nongenetic parental conditions and the risk of perimembranous ventricular septal defects (pVSD) in offspring.
  • To identify specific modifiable risk factors for pVSD that can be addressed through preconception counseling.
  • To contribute to the primary prevention of congenital heart disease.

Main Methods:

  • A case-control study involving 115 parents of children with pVSD and 484 parents of healthy children.
  • Standardized data collection occurred 17 months post-birth, utilizing questionnaires on periconceptional nongenetic conditions.
  • Univariable and multivariable logistic regression analyses were employed to calculate odds ratios (OR) and 95% confidence intervals (95% CI).

Main Results:

  • Maternal risk factors associated with pVSD offspring included a positive family history of congenital heart disease (OR, 2.61), medication use (OR, 1.80), and advanced maternal age (OR, 1.07).
  • Paternal exposure to phthalates was identified as a significant risk factor (OR, 1.93).
  • Complete data were obtained from 588 families, representing a 98% participation rate.

Conclusions:

  • Four periconceptional parental conditions were found to significantly contribute to the risk of pVSD in offspring.
  • Couples planning pregnancy should receive counseling regarding these identified risk factors.
  • These risk conditions are partially modifiable, offering potential avenues for the primary prevention of pVSDs.
Abstract

Related Concept Videos

Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart...
3.8K
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.8K
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
1.1K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
569
Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
5.0K